Process Chromatography: Five Decades of Innovation - - BioPharm International


Process Chromatography: Five Decades of Innovation

BioPharm International
Volume 20, Issue 10

50. Shukla AA, Hubbard B, Tressel T, Guhan S, Low D. Downstream processing of monoclonal antibodies—application of platform technologies. J Chrom B. 2007 Mar 15;848(1):28-39.

51. Afeyan NB, Gordon NF, Mazsaroff I, Varady L, Fulton SP, Yang YB, Regnier FE. Flow-through particles for the high-performance liquid chromatographic separation of biomolecules: perfusion chromatography. J Chromatogr. 1990;519:1-29.

52. Wurm FM. Production of recombinant protein therapeutics in cultivated mammalian cells. Nature Biotechnol. 2004;22(11):1393–1398.

53. Langer E, Ranck J. Capacity bottleneck squeezed by downstream processes. BioProcess Int. 2006;4(3):14–18.

54. Sofer GK, Chirica LC. Improving productivity in downstream processing. BioPharm Int. 2006;19(11):48–55.

55. Low D, O'Leary R, Pujar NS. Future of antibody purification. J Chromatogr. 2007 Mar 15;848(1):48-63.

56. Ghosh R. Protein separation using membrane chromatography: opportunities and challenges. J Chromatogr. 2002;A 952:13-27.

57. Brandt S, Goffe RA, Kessler SB, O'Connor JL, Zale S. Membrane-based affinity technology for commercial scale purifications. Bio/Technology. 1988;6:779-782.

58. Tennikova TB, Reusch J. Short monolithic beds: history and introduction to the field. J Chromatogr. A. 2005;1065(1):13-7.

59. Tennikova TB, Bleha M, Svec F, Almazova TV, Belenkii BG. High-performance membrane chromatography of proteins: A novel method of protein separation. J Chromatogr. 1991;555:97-107.

60. Champluvier B, Kula R-M. Microfiltration Membranes as Pseudo-Affinity Adsorbants: Modification and Comparison with Gel Beads. J. Chromatogr. 1991;539:315-325.

61. Langlotz P, Kroner KH. Surface-modified membranes as a matrix for protein purification. J Chromatogr. 1992;591:107-113.

62. Gebauer KH, Thömmes J, Kula MR. Breakthrough performance of high-capacity membrane adsorbers in protein chromatography. Chem Eng Sci. 1997;52(3),405-419.

63. Reichert U, Linden Th, Belfort G, Kula M-R, Thömmes J. Visualisation of protein adsorption to ion-exchange membranes by confocal microscopy. J Membr Sci. 1997;161-166,2002.

64. Zhou J, Tressel T. Basic concepts in Q membrane chromatogtaphy for large-scale antibody production. Biotechnol Prog. 2006;22(2),341-349.

65. Lim JAC, Sinclair A, Kim DS, Gottschalk U. Economic benefits of single-use membrane chromatography in polishing. BioProcess Int. Feb 2007.

66. Knudsen H, Fahrner R, Xu Y, Norling L, Blank G. Membrane ion-exchange chromatography for process-scale antibody purification. J Chromatogr. 2001;A 907:145-154.

67. Przybycien TM, Pujar NS, Steele LM. Alternative bioseparations: life beyond packed bed chromatography. Curr Opin Biotechnol. 2004;15:469–478.

68. Buchacher A, Iberer G. Purification of intravenous immunoglobulin G from human plasma—aspects of yield and virus safety. Biotechnol J. 2006;2:148–163.

69. Lander RJ, Winters MA, Meacle FJ, Buckland BC, Lee AL. Fractional precipitation of plasmid DNA from lysate by CTAB. Biotechnol Bioeng. 2002;79(7):776–84.

70. Fulton SP, Shahidi AJ, Gordon NF, Afeyan NB. Large-scale processing and high-throughput perfusion chromatography. Biotechnol. 1992;10(6):635–639.

71. Strancar A, Podgornik A, Barut M, Necina R. Short monolithic columns as stationary phases for biochromatography. Adv Biochem Eng Biotechnol. 2002;76:49–85.

72. Guhan J, Li YF, Moore JA, Cramer SM. Ion-exchange displacement chromatography of proteins. Dendritic polymers as novel displacers. J Chrom A. 1995;702:143–155.

73. Curling JM. Affinity chromatography: from textile dyes to synthetic ligands by design. BioPharm Int. 2004;17(7): 34–42 and 17(8):60–66.

74. Cabanne C, Raedts M, Zavadsky E, Santarelli X. Evaluation of radial chromatography versus axial chromatography, a practical approach. J Chrom B. 2007 Jan 15;845(2):191-9.

75. Janson JC. The development of gel media and columns for large scale chromatography of proteins. A historical review and visions for the future. Recovery of biological products X, Cancún, Mexico;2001, Jun 3–8.

blog comments powered by Disqus



GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
USP Joins Chinese Pharmacopoeia Commission for Annual Science Meeting
November 20, 2014
Author Guidelines
Source: BioPharm International,
Click here